Amid backlash, Novo Nordisk reports positive cardiovascular profile for Wegovy

Wegovy has been approved in the US and Europe for weight loss management in patients aged 12 years and older.

Aug 8, 2023 - 20:00

Wegovy has been approved in the US and Europe for weight loss management in patients aged 12 years and older.

Read the original article

Tags:

Previous Article

Arcus and Gilead terminate development for etrumadenant in prostate cancer

Jacobio Pharma receives breakthrough therapy designation for glecirasib

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

STAT+: With an age cutoff for a new gene therapy, families and doctors scramble to treat kids before their 6th birthday

STAT+: With an age cutoff for a new gene therapy, famil...

Aug 17, 2023

NIH begins long-delayed clinical trials for long Covid, announces new research office

NIH begins long-delayed clinical trials for long Covid,...

Aug 1, 2023

Abdera raises funds to advance radiopharmaceuticals to treat cancer

Abdera raises funds to advance radiopharmaceuticals to ...

Apr 20, 2023